KOHJIN BIO CO LTDKOHJIN BIO CO LTDKOHJIN BIO CO LTD

KOHJIN BIO CO LTD

No trades
See on Supercharts

177A fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Kohjin Bio Co., Ltd. engages in the manufacture and sale of animal blood, serums, tissue culture media and other products. It operates through the following business segments. Tissue Culture Business, Microbiology Business and Cell Processing Business. The Tissue Culture business segment engages in the manufactures, and sale of tissue culture media, including serum free media used for research purposes in regenerative medicine and immunotherapy. The Microbiology business segment develops, manufactures, and sells a wide variety of microorganism detection media used for pathogen testing in the clinical and food fields, and quality testing in various fields such as pharmaceuticals and cosmetics. The Cell Processing business segment conducts cell processing operations under contract from medical institutions. The company was founded by Takato Nakamura in April 1981 and is headquartered in Sakado, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

177A does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company